Glycaemic fluctuation predicts mortality in critically ill patients

Anaesthesia and Intensive Care

Volumn 38, Issue 4, 2010, Pages 695-702

  Al Dorzi, H M ^a   Tamim, H M ^a,b   Arabi, Y M ^a,b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b King Faisal Medical City for Southern Region   (Saudi Arabia)

Author keywords

Critical care; Critical illness; Glucose; Insulin; Intensive care

Indexed keywords

GLUCOSE; INSULIN; ISOPHANE INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RANDOMIZED CONTROLLED TRIAL; AGE; AGED; CRITICAL ILLNESS; DOSE RESPONSE; DRUG EFFECT; INTENSIVE CARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; COHORT STUDIES; CRITICAL ILLNESS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 77956627291     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1003800413     Document Type: Article

References (24)

1. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005; 19:178-181.
2. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna R C, Moghetti P et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000; 23:45-50. (Pubitemid 30022893)
3. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478.
4. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366. (Pubitemid 36232926)
5. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000.
6. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461. (Pubitemid 43200296)
7. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
8. NICE-SUGAR study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
9. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252. (Pubitemid 44148168)
10. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36:3008-3013.
11. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish zA, Haddad SH et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36:3190-3197.
12. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19:19-35.
13. Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36:2316-2321.
14. Preiser J-C, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007; 35:503-507.
15. Wintergerst KA, Buckingham B, Gandrud l, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179.
16. Kovatchev BP, Otto E, Cox D, Gonder-Frederick l, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006; 29:2433-2438.
17. Quagliaro l, Piconi l, Assaloni R, Martinelli l, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52:2795-2804.
18. Monnier l, Mas E, Ginet C, Michel F, Villon L, Cristol J-P et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-1687.
19. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195.
20. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10:46-52.
21. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28:1231-1239. (Pubitemid 40616646)
22. Garg S, zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29:44-50.
23. Hoedemaekers CWE, Klein Gunnewiek JMT, Prinsen MA, Willems Jl, Van der Hoeven JG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 2008; 36:3062-3066.
24. Meynaar IA, van Spreuwel M, Tangkau Pl, Dawson l, Sleeswijk VS, Rijks L et al. Accuracy of AccuChek glucose measurement in intensive care patients. Crit Care Med 2009; 37:2691-1696.